tirzepatide clinical trial enrollment for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN Tirzepatide in Adults With Type

Together, we can achieve your health goals without compromising your well-being

A quick reminder about safety and expectations Even when a drug is next-generation, the basics still matter: Start low, titrate thoughtfully Prioritize protein + strength training to protect lean mass Manage GI side effects proactively Monitor body composition and your overall health during weight loss And most importantly, avoid non-prescribed or grey market productsnew options may seem appealing, but true safety comes only from medically supervised, high-quality medications

Nursing Research 59:270-279, 2010

Results: The 90% confidence intervals were 93.11%107.22% for Cmax, 93.76%112.65% for AUC0t, and 91.48%104.47% for AUC0, meeting bioequivalence criteria for all primary parameters

Statistical analysis Changes in SBP, DBP and hsCRP from SURMOUNT-OSA have already been reported using treatment-regimen estimand analysis 13

Because melanocortin modulation of energy homeostasis is centrally mediated, drug developers must overcome large pharmacokinetic hurdles for CNS penetration (141)